Prospective Study of Insulin Resistance and Cardiovascular Disease Risk During Androgen Deprivation Therapy for Prostate Cancer

NCT00455624 · clinicaltrials.gov ↗

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Androgen deprivation therapy

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]
[object Object]